CLEVELAND, Aug. 31 /PRNewswire/ -- Cleveland-based The ScottCare Corporation, a leader in non-invasive external counterpulsation (ECP) therapy and cardiopulmonary rehabilitation telemetry, announced today that the company has completed the previously announced acquisition of the operations of Rozinn Electronics, Inc., a privately-held market leader in cardiovascular diagnostic equipment based in Glendale, NY.
"We are very pleased to welcome the customers, employees and vendors of Rozinn to ScottCare," said Ken Zajaczkowski, General Manager of The ScottCare Corporation. "We are excited about the opportunities created by adding Rozinn's leading portfolio of diagnostic products and distribution network. ScottCare can now provide products across the spectrum of cardiac care - diagnosis, treatment and rehabilitation, meeting the needs of cardiology customers worldwide."
The acquisition strengthens ScottCare's position in non-invasive and diagnostic cardiology device markets around the world. ScottCare will accelerate development, marketing and support for Rozinn's diagnostic product suite including Holter for Windows+(R), Pacemaker and Event Monitoring Products. In addition, ScottCare will expand the availability of its leading cardiac rehab telemetry and ECP therapy products outside North America through Rozinn's extensive international network of dealers.
Rozinn key personnel, including Mark Rosoff, Karl Ziemann, Sneh Merchant and George Falcone, will continue to play a key roll in the further development and growth of Rozinn's diagnostic product line.
For more information, call 1-800-243-9412, ext. 133 or visit http://www.scottcare.com.
About The ScottCare Corporation
Since 1989, The ScottCare Corporation has developed, manufactured and
marketed quality medical devices for non-invasive cardiology therapy and
cardiopulmonary rehabilitation professionals. ScottCare is committ
|SOURCE The ScottCare Corporation|
Copyright©2007 PR Newswire.
All rights reserved